Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel DiseaseSummary

Background & Aims: Mucosal-associated invariant T (MAIT) cells are innate-like T cells restricted by major histocompatibility complex-related molecule 1 (MR1) and express a semi-invariant T cell receptor. Previously, we reported the activation status of circulating MAIT cells in patients wit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yusuke Yasutomi, Asako Chiba, Keiichi Haga, Goh Murayama, Ayako Makiyama, Taiga Kuga, Mamoru Watanabe, Ryuichi Okamoto, Akihito Nagahara, Takashi Nagaishi, Sachiko Miyake
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/5a5fdbd058f24ba1a8de703e5edfd09c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5a5fdbd058f24ba1a8de703e5edfd09c
record_format dspace
spelling oai:doaj.org-article:5a5fdbd058f24ba1a8de703e5edfd09c2021-11-14T04:34:16ZActivated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel DiseaseSummary2352-345X10.1016/j.jcmgh.2021.08.018https://doaj.org/article/5a5fdbd058f24ba1a8de703e5edfd09c2022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352345X21001855https://doaj.org/toc/2352-345XBackground & Aims: Mucosal-associated invariant T (MAIT) cells are innate-like T cells restricted by major histocompatibility complex-related molecule 1 (MR1) and express a semi-invariant T cell receptor. Previously, we reported the activation status of circulating MAIT cells in patients with ulcerative colitis (UC) was associated with disease activity and that these cells had infiltrated the inflamed colonic mucosa. These findings suggest MAIT cells are involved in the pathogenesis of inflammatory bowel disease. We investigated the role of MAIT cells in the pathogenesis of colitis by using MR1−/− mice lacking MAIT cells and a synthetic antagonistic MR1 ligand. Methods: Oxazolone colitis was induced in MR1−/− mice (C57BL/6 background), their littermate wild-type controls, and C57BL/6 mice orally administered an antagonistic MR1 ligand, isobutyl 6-formyl pterin (i6-FP). Cytokine production of splenocytes and colonic lamina propria lymphocytes from mice receiving i6-FP was analyzed. Intestinal permeability was assessed in MR1−/− and i6-FP-treated mice and their controls. The effect of i6-FP on cytokine production by MAIT cells from patients with UC was assessed. Results: MR1 deficiency or i6-FP treatment reduced the severity of oxazolone colitis. i6-FP treatment reduced cytokine production in MAIT cells from mice and patients with UC. Although MR1 deficiency increased the intestinal permeability, i6-FP administration did not affect gut integrity in mice. Conclusions: These results indicate MAIT cells have a pathogenic role in colitis and suppression of MAIT cell activation might reduce the severity of colitis without affecting gut integrity. Thus, MAIT cells are potential therapeutic targets for inflammatory bowel disease including UC.Yusuke YasutomiAsako ChibaKeiichi HagaGoh MurayamaAyako MakiyamaTaiga KugaMamoru WatanabeRyuichi OkamotoAkihito NagaharaTakashi NagaishiSachiko MiyakeElsevierarticleMAIT CellMucosal ImmunityInflammatory Bowel DiseaseGut IntegrityDiseases of the digestive system. GastroenterologyRC799-869ENCellular and Molecular Gastroenterology and Hepatology, Vol 13, Iss 1, Pp 81-93 (2022)
institution DOAJ
collection DOAJ
language EN
topic MAIT Cell
Mucosal Immunity
Inflammatory Bowel Disease
Gut Integrity
Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle MAIT Cell
Mucosal Immunity
Inflammatory Bowel Disease
Gut Integrity
Diseases of the digestive system. Gastroenterology
RC799-869
Yusuke Yasutomi
Asako Chiba
Keiichi Haga
Goh Murayama
Ayako Makiyama
Taiga Kuga
Mamoru Watanabe
Ryuichi Okamoto
Akihito Nagahara
Takashi Nagaishi
Sachiko Miyake
Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel DiseaseSummary
description Background & Aims: Mucosal-associated invariant T (MAIT) cells are innate-like T cells restricted by major histocompatibility complex-related molecule 1 (MR1) and express a semi-invariant T cell receptor. Previously, we reported the activation status of circulating MAIT cells in patients with ulcerative colitis (UC) was associated with disease activity and that these cells had infiltrated the inflamed colonic mucosa. These findings suggest MAIT cells are involved in the pathogenesis of inflammatory bowel disease. We investigated the role of MAIT cells in the pathogenesis of colitis by using MR1−/− mice lacking MAIT cells and a synthetic antagonistic MR1 ligand. Methods: Oxazolone colitis was induced in MR1−/− mice (C57BL/6 background), their littermate wild-type controls, and C57BL/6 mice orally administered an antagonistic MR1 ligand, isobutyl 6-formyl pterin (i6-FP). Cytokine production of splenocytes and colonic lamina propria lymphocytes from mice receiving i6-FP was analyzed. Intestinal permeability was assessed in MR1−/− and i6-FP-treated mice and their controls. The effect of i6-FP on cytokine production by MAIT cells from patients with UC was assessed. Results: MR1 deficiency or i6-FP treatment reduced the severity of oxazolone colitis. i6-FP treatment reduced cytokine production in MAIT cells from mice and patients with UC. Although MR1 deficiency increased the intestinal permeability, i6-FP administration did not affect gut integrity in mice. Conclusions: These results indicate MAIT cells have a pathogenic role in colitis and suppression of MAIT cell activation might reduce the severity of colitis without affecting gut integrity. Thus, MAIT cells are potential therapeutic targets for inflammatory bowel disease including UC.
format article
author Yusuke Yasutomi
Asako Chiba
Keiichi Haga
Goh Murayama
Ayako Makiyama
Taiga Kuga
Mamoru Watanabe
Ryuichi Okamoto
Akihito Nagahara
Takashi Nagaishi
Sachiko Miyake
author_facet Yusuke Yasutomi
Asako Chiba
Keiichi Haga
Goh Murayama
Ayako Makiyama
Taiga Kuga
Mamoru Watanabe
Ryuichi Okamoto
Akihito Nagahara
Takashi Nagaishi
Sachiko Miyake
author_sort Yusuke Yasutomi
title Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel DiseaseSummary
title_short Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel DiseaseSummary
title_full Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel DiseaseSummary
title_fullStr Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel DiseaseSummary
title_full_unstemmed Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel DiseaseSummary
title_sort activated mucosal-associated invariant t cells have a pathogenic role in a murine model of inflammatory bowel diseasesummary
publisher Elsevier
publishDate 2022
url https://doaj.org/article/5a5fdbd058f24ba1a8de703e5edfd09c
work_keys_str_mv AT yusukeyasutomi activatedmucosalassociatedinvarianttcellshaveapathogenicroleinamurinemodelofinflammatoryboweldiseasesummary
AT asakochiba activatedmucosalassociatedinvarianttcellshaveapathogenicroleinamurinemodelofinflammatoryboweldiseasesummary
AT keiichihaga activatedmucosalassociatedinvarianttcellshaveapathogenicroleinamurinemodelofinflammatoryboweldiseasesummary
AT gohmurayama activatedmucosalassociatedinvarianttcellshaveapathogenicroleinamurinemodelofinflammatoryboweldiseasesummary
AT ayakomakiyama activatedmucosalassociatedinvarianttcellshaveapathogenicroleinamurinemodelofinflammatoryboweldiseasesummary
AT taigakuga activatedmucosalassociatedinvarianttcellshaveapathogenicroleinamurinemodelofinflammatoryboweldiseasesummary
AT mamoruwatanabe activatedmucosalassociatedinvarianttcellshaveapathogenicroleinamurinemodelofinflammatoryboweldiseasesummary
AT ryuichiokamoto activatedmucosalassociatedinvarianttcellshaveapathogenicroleinamurinemodelofinflammatoryboweldiseasesummary
AT akihitonagahara activatedmucosalassociatedinvarianttcellshaveapathogenicroleinamurinemodelofinflammatoryboweldiseasesummary
AT takashinagaishi activatedmucosalassociatedinvarianttcellshaveapathogenicroleinamurinemodelofinflammatoryboweldiseasesummary
AT sachikomiyake activatedmucosalassociatedinvarianttcellshaveapathogenicroleinamurinemodelofinflammatoryboweldiseasesummary
_version_ 1718429958129319936